Treasury & EBT Shares Issued

Science Group PLC
16 October 2023
 

 

16 October 2023

 

Science Group plc

(the "Company" or "Science Group")

 

Treasury and EBT shares issued

 

Science Group plc (AIM:SAG) announces that on 13 October 2023 the Company issued 5,201 shares from treasury and 4,799 shares from the Frontier Smart Technologies Employee Benefit Trust, each at an average price of 1 pence per share in settlement of the exercise of share options. 

 

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 45,931,707.  Science Group holds 254,167 shares in treasury and there are no shares remaining in the Frontier Smart Technologies Employee Benefit Trust.  The total number of voting rights in the Company following this announcement is therefore 45,931,707.

 

The figure of 45,931,707 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.

 

 

- Ends -

 

 

For further information:

Science Group plc


Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

www.sciencegroup.com  

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)


Nick Adams, Alex Price, Richard Short

Tel: +44 (0) 20 7710 7600



Liberum Capital Limited (Joint Broker)


Max Jones, Miquela Bezuidenhoudt

Tel: +44 (0) 20 3100 2000




 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings